Collin Sinclair

About Collin Sinclair

Highly accomplished, results-oriented National Account Director. Proven track record of building relationships with key decision-makers, developing sound contracting strategies, achieving favorable product access, and increasing sales for large, diverse specialty and non-specialty portfolios. Possess 24 years of industry experience in Sales, Marketing, Sales Management, and Managed Markets. Have unique ability as a pharmacist to approach business from a clinical and highly credible perspective. Specific areas of Expertise: National Accounts, Regional Accounts, Gene Therapy, Oncology, Specialty (Contracted and Non-Contracted), Rare Disease, Contracting, Medical Benefit, Buy and Bill, Specialty Pharmacy, Medical Policy, and Site of Care. Therapeutic Background: Gene Therapy, Oncology, IG, Bleeding Disorders, Gastroenterology, Lysosomal Storage Disorders, Endocrinology, Pulmonology, Nephrology; Non-Specialty - Diabetes, Cardiovascular, Gastroenterology, Neuroscience, Nephrology, Rheumatology, Obesity, Ophthalmology

Experience

1. Director, National Accounts

   诺华

   May 2023 — Present · Charlotte, NC, US

   Support Zolgensma in the gene therapy space with national, regional, and Medicaid accounts in the eastern 1/3 of the US. National account responsibilities include Express Scripts/Cigna, Elevance, and Magellan. Also support key regional and FFS Medicaid accounts in the Northeast, Mid-Atlantic, and Southeast regions, including Puerto Rico. Currently manage numerous VBCs to ensure appropriate coverage for Zolgensma. Work as part of cross-functional team to reduce barriers and ensure timely treatment for optimal patient outcomes.

Education

• Louisiana State University

  MBA

  1997 — 1999

• Louisiana Tech University

  BS, Zoology/Animal Biology

  1990 — 1993

• University of Louisiana Monroe

  BS, Pharmacy

  1992 — 1995

• Shenandoah University

  PharmD

  2010 — 2012